![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
REMDESIVIR REDUCES MORTALITY IN
IMMUNOCOMPROMISED PATIENTS HOSPITALIZED FOR COVID-19
|
|
|
CROI 2023 Feb 20-23
Essy Mozaffari1, Aastha Chandak2, Robert L Gottlieb3, Andre C Kalil4, Stephanie H Read5, Heng Jiang6, Mel Chiang7, EunYoung Lee1, Rikisha Gupta1,
Mark Thrun1, Chidinma Chima-Melton8
1Gilead Sciences, Foster City, CA; 2Certara, New York, NY; 3Baylor Scott and White Research Institute, Dallas, TX; 4University of Nebraska Medical Center, Omaha, NE; 5Certara, London, UK; 6Certara, Paris, France; 7Gilead Sciences, Taipei, Taiwan; 8UCLA Health, Torrance, CA
![0322231](../images/032223/032223-2/0322231.gif)
![0322232](../images/032223/032223-2/0322232.gif)
![0322233](../images/032223/032223-2/0322233.gif)
![0322234](../images/032223/032223-2/0322234.gif)
![0322235](../images/032223/032223-2/0322235.gif)
![0322236](../images/032223/032223-2/0322236.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|